U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 7-13, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 7-13, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 07/11/2024
Location: Silver Spring, MD
Subject: Evaluating Immunosuppressive Effects of In Utero Exposure to Drug and Biologic Products Public Workshop
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, industry, government, media, and other registered attendees

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 07/08/2024
Location: Arlington, VA
Subject: FDA's Human Foods Program Budget
FDA Participant/Group: KARI BARRETT; ERIK METTLER; JEFFREY FARRAR; BARBARA CASSENS; STELLA SPYROPOULOS;
Non FDA Participant/Group: Becky Garrison Warfel, Bob Ehart, Joe Reardon, Ted McKinney (National Association of State Departments of Agriculture); Karen Ross (California Department of Food and Agriculture); Bryan Hurlburt (Connecticut Department of Agriculture); Richard Ball (New York Department of Agriculture and Markets);

Event Date: 07/09/2024
Location: Virtual
Subject: International Dairy Foods Association Regulatory RoundUP; Speaker: Transformation of FDA Human Foods Program
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the International Dairy Foods Association, industry, and federal regulatory officials

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 07/09/2024
Location: Geneva, Switzerland
Subject: Meeting of the World Health Organization’s (WHO) Steering Committee of the Member State Mechanism on Substandard and Falsified Medical Products
FDA Participant/Group: MICAH AUGUSMA;
Non FDA Participant/Group: Steering committee members

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

Event Date: 07/10/2024
Location: Virtual
Subject: International Dairy Foods Association Regulatory RoundUP; Speaker: Updates from FDA’s Associate Commissioner for Regulatory Affairs
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the International Dairy Foods Association, industry, and federal regulatory officials

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/10/2024
Location: Virtual
Subject: Boston University-Center on Emerging Infectious Diseases Workshop: Expanded Access Programs for Special Pathogens; Speaker: Opening Remarks - Network Preparedness and Enhancing Global Coordination
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academic, and government stakeholders

Event Date: 07/12/2024
Location: Virtual
Subject: Cell and Gene Therapy Conference, Suzhou, China; Speaker: Advancing the Development of Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, academic, and government stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 07/09/2024
Location: Silver Spring, MD
Subject: Direct-to-Consumer Orthodontics
FDA Participant/Group: ANITA BELANI; BOBAK SHIRMOHAMMADI; MARIE KAO-HSIEH; LEAH ROYCE; SRINIVAS NANDKUMAR;
Non FDA Participant/Group: Alexandra Campau, Cosmo Haralambidis, Dale Anne Featheringham, Jashleen Bedi, John D. Callahan, Kenneth Webb, Mackenzie Butcher, Michael G. Durbin, Nathan Mick, Trey Lawrence (American Association of Orthodontists);

Event Date: 07/10/2024
Location: Virtual
Subject: Bank of America Securities Washington DC Health Care Conference; Speaker: Keynote - CDRH Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Institutional investors and mutual fund managers

Event Date: 07/11/2024
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: TROY TAZBAZ; VIVEK PINTO; PAMELA SCOTT; DAVID MCMULLEN; JAY GUPTA;
Non FDA Participant/Group: Joe Powers, Hagai Lalazar, Gidi Littwin (Cognitiv)

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 07/08/2024
Location: Silver Spring, MD
Subject: Australia Vet Services Division of the Department of Agriculture, Fisheries, and Forestry Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of Australian Department of Agriculture, Fisheries and Forestry (DAFF)

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top